Osteoprotegerin predicts cardiovascular events in patients treated with haemodialysis

Ping-Hsun Wu1,2,3, Rie Io Glerup4, My Hanna Sofia Svensson5,6

  • 1Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Insights

Osteoprotegerin (OPG) is linked to cardiovascular events (CVEs) in hemodialysis patients, independent of inflammation. Other bone biomarkers

Area of Science:

  • Bone mineral metabolism
  • Cardiovascular disease biomarkers
  • Proteomics

Background:

  • Disturbances in bone metabolism are linked to mortality and cardiovascular events (CVEs).
  • The independent association of bone-associated protein biomarkers with mortality and CVEs, separate from cytokine activation, is not well understood.
  • This study investigates bone-associated proteins, inflammatory cytokines, and cardiovascular outcomes.

Purpose of the Study:

  • To examine nine bone-associated proteins in hemodialysis patients.
  • To assess the association of these proteins with all-cause death, cardiovascular death, and CVEs.
  • To determine if these associations are independent of inflammatory cytokines.

Main Methods:

  • Prospective study of 331 hemodialysis patients.
  • Proximity extension proteomics assay used to measure nine bone-associated proteins.
  • Random forest algorithm evaluated marker importance; Cox models analyzed associations with outcomes, adjusting for confounders and inflammatory proteins.

Main Results:

  • Cathepsin L1 (CTSL1) remained associated with all-cause death; four biomarkers were linked to CVEs after initial adjustment.
  • Associations between most bone markers and outcomes were attenuated after adjusting for inflammatory proteins.
  • Osteoprotegerin (OPG) was the most important marker for CVEs and improved prediction models, independent of cytokine activity.

Conclusions:

  • Osteoprotegerin (OPG) is associated with cardiovascular events (CVEs) independently of cytokine activity.
  • The association of TRAIL receptor 2 (TRAIL-R2), cathepsin D (CTSD), and cathepsin L1 (CTSL1) with CVEs is influenced by inflammatory cytokine activity.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
284
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
469
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
108
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
432
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
965
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
42